TAB1 and diabetic kidney disease: In diabetic kidney disease, high glucose levels promote macrophage activation via HIF-1α activation mediated by TGF-β-activated kinase 1-binding protein-1 (TAB1), and inhibiting TAB1 alleviates kidney inflammation and disease progression (Zeng et al., 2020).